Clinical, epidemiological and virological findings of the first COVID-19 outbreak in Medellín, Antioquia, Colombia
DOI:
https://doi.org/10.17533/udea.rfnsp.e344675Keywords:
Wuhan coronavirus outbreak, COVID-19, Medellín (Colombia), public health surveillanceAbstract
Objective: To characterize clinically, epidemiologically and virologically the first outbreak of covid-19, from the primary case in Medellín (Colombia), through surveillance and epidemiological control carried out for its containment.
Methodology: Retrospective descriptive study. Secondary cases are identified taking into account the definition of the protocol of the National Institute of Health. Data collection was obtained of the Public Health Surveillance System, research epidemiological field, medical history and results of laboratory. Clinical patterns of the disease (signs and symptoms), epidemiological components (transmission surveillance and control actions) and virological (with the use of the diagnostic test for sars-CoV-2 and the evaluation of virological recovery). The confirmation of the cases was done by the diagnostic detection technique of Wuhan coronavirus 2019 by reverse transcription polymerase Chain Reaction - Real Time, Charité protocol, Berlin, Germany 2020, processed in and reported by the National Laboratory of Reference of the National Institute of Health.
Results: The Medellín's primary case entered the country on March 2, 2020, from Madrid (Spain) and was confirmed on March 9. 52 close contacts were identified in 9 clusters. The surveillance actions in public health made it possible to identify 5 related cases in an early phase of the disease.
Conclusions: The characterization of the primary case in Medellín seek to identify the first outbreak of covid-19 and guide the epidemiological control measures, such as isolations, intakes of samples, follow-up contacts and case searches secondary
Downloads
References
World Health Organization. Novel Coronavirus (2019-nCoV). Situation Report - 1 21 January 2020 [internet]; 2020 [citado 2020 may. 21]. Disponible en: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf
World Health Organization. Novel Coronavirus ( 2019-nCoV ). Situation Report - 10 [internet]. 2020. [citado 2020 may. 21] . Disponible en: https://apps.who.int/iris/handle/10665/330775
World Health Organization. Novel Coronavirus ( 2019-nCoV ). Situation Report - 11 [internet]. 2020. [citado 2020 may. 21]. Disponible en: https://apps.who.int/iris/handle/10665/330776
Pan American Health Organization, World Health Organization. Actualización epidemiológica: enfermedad por coronavirus - (covid-19) 20 de abril de 2020 [internet]; 2020 [citado 2020 may. 21]. Disponible en: https://www.paho.org/es/documentos/actualizacion-epidemiologica-enfermedad-por-coronavirus-covid-19-20-abril-2020
World Health Organization. Coronavirus disease 2019 (covid-19): Situation Report 51 - 11th March 2020 [internet]; 2020 [citado 2020 may. 21]. Disponible en: https://apps.who.int/iris/handle/10665/331475
Organización Panamericana de la Salud (ops), Organización Mundial de la Salud (oms). Respuesta de la ops/oms. 31 de marzo del 2020. Informe N.o 1 [internet]; 2020 [citado 2020 may. 21]. Disponible en: https://iris.paho.org/bitstream/handle/10665.2/52404/COVID-19SitRep1_spa.pdf?sequence=1&isAllowed=y
Instituto Nacional de Salud. Protocolo de vigilancia en salud pública. Infección Respiratoria Aguda (ira) códigos: 345, 348, 591, 995 [internet]; 2020. [citado 2020 may. 21]. Disponible en: https://www.ins.gov.co/buscador-eventos/Lineamientos/Pro_Infección respiratoria aguda.pdf
Instituto Nacional de Salud. (covid-19), Anexo. Instructivo para la vigilancia en salud pública intensificada de infección respiratoria aguda asociada al nuevo coronavirus 2019.
Instituto Nacional de Salud . Dirección de Vigilancia y Análisis del Riesgo en Salud Pública, Grupo de Formación de Talento Humano para la Vigilancia en Salud Pública. Lineamientos para la elaboración de productos gfth. Lineamientos para la elaboración de productos gfth - Atención de brotes o emergencias en salud pública [internet]; 2016. [citado 2020 may. 21]. Disponible en: https://www.ins.gov.co/Direcciones/Vigilancia/Lineamientosydocumentos/Manual de ateción a brotes.pdf
Ortiz-Prado E, Simbaña-Rivera K, Gómez-Barreno L, et al. Clinical, molecular, and epidemiological characterization of the sars-CoV-2 virus and the Coronavirus Disease 2019 (covid-19), acomprehensive literature review. Diagn Microbiol Infect Dis. 2020; 98(1). doi: https://doi.org/10.1016/j.diagmicrobio.2020.115094
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-Infected pneumonia in Wuhan, China. jama. 2020;323(11):1061-9. doi: https://doi.org/10.1001/jama.2020.1585
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395(10223):507-13. doi: http://dx.doi.org/10.1016/S0140-6736(20)30211-7
Sultan S, Altayar O, Siddique SM, et al. aga Institute rapid review of the gastrointestinal and liver manifestations of covid-19, meta-analysis of international data, and recommendations for the consultative management of patients with covid-19. Gastroenterology. 2020;159(1):320-334.e27. doi: http://dx.doi.org/10.1053/j.gastro.2020.05.001
Zahra SA, Iddawela S, Pillai K, et al. Can symptoms of anosmia and dysgeusia be diagnostic for covid-19? Brain Behav. 2020;10(1):1-18. https://doi.org/10.1002/brb3.1839
Carrillo-Larco RM, Altez-Fernandez C. Anosmia and dysgeusia in covid-19: A systematic review [versión 1; peer review: 2 approved, 1 not approved]. Wellcome Open Res 2020;5:94. doi: https://doi.org/10.12688/wellcomeopenres.15917.1
Meng X, Deng Y, et al. covid-19 and anosmia: A review based on up-to-date knowledge. Am J Otolaryngol. 2020;41(5):102581. doi: https://doi.org/10.1016/j.amjoto.2020.102581
Bi Q, Wu Y, Mei S, et al. Epidemiology and transmission of covid-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: A retrospective cohort study. Lancet Infect Dis. 2020;20(8):911-9. doi: https://doi.org/10.1016/S1473-3099(20)30287-5
Chan JFW, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet. 2020;395(10223):514-23. doi: http://dx.doi.org/10.1016/S0140-6736(20)30154-9
Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveillance. 2020;25(5):20-28. doi: https://doi.org/10.2807/1560-7917.ES.2020.25.5.2000062
Organización Mundial de Salud. Preguntas y respuestas sobre la enfermedad por coronavirus (covid-19) [internet]. s. f. [citado 2020 may. 21]. Disponible en: https://www.who.int/es/emergencies/diseases/novel-coronavirus-2019/advice-for-public/q-a-coronaviruses
Centers for Disease Control and Prevention. Symptoms of covid-19 [internet]. s. f. [citado 2020 may. 21]. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
Sheng W-H, Liu W-D, Wang J-T, et al. Dysosmia and dysgeusia in patients with covid-19 in northern Taiwan. J Formos Med Assoc. 2020;120(1 Parte 2):311-7. doi: https://doi.org/10.1016/j.jfma.2020.10.003
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Universidad de Antioquia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The contents of the articles are the responsibility of the authors
The editorial committee has editorial independence from the National School of Public Health "Héctor Abad Gómez" of the University of Antioquia.
The editorial committee is not responsible for aspects related to copying, plagiarism or fraud that may appear in the articles published in it.
When you are going to reproduce and disclose photographs or personal data in printed or digital format, informed consent is required. Therefore, this requirement is required of the author at the time of receipt of the manuscript.
Authors are responsible for obtaining the necessary permissions to reproduce any material protected by reproduction rights.
The authors preserve the moral rights and assign the economic rights that will correspond to the University of Antioquia, to publish it, distribute electronic copies, include them in indexing services, directories or national and international databases in Open Access, under the Creative Commons Attribution license -Not Commercial-Share Equal 4.0 International Commercial (CC BY-NC-SA) which allows others to distribute, remix, retouch, and create from the work in a non-commercial way, as long as the respective credit and license are granted. new creations under the same conditions.
The authors will sign the declaration of transfer of economic rights to the University of Antioquia, after the acceptance of the manuscript.
The editorial committee reserves the right to reject the articles whose authors do not offer satisfactory explanations about the contribution of each author, to meet the criteria of authorship in the submission letter. All authors must meet the four criteria of authorship according to ICMJE: "a) .- That there is a substantial contribution to the conception or design of the article or to the acquisition, analysis or interpretation of the data. b) That they have participated in the design of the research work or in the critical review of its intellectual content. c) .- That has been intervened in the approval of the final version that will be published.d). That they have the capacity to respond to all aspects of the article in order to ensure that issues related to the accuracy or integrity of any part of the work are adequately investigated and resolved. "
-- 
--
